.jpg?format=webp&width=780)
The present article discusses the relationship between obstructive sleep apnea (OSA) and metabolic syndrome (MS), which is a condition associated with increased cardiovascular risk. The article suggests that OSA is associated with prevalent and incident components of MS and MS itself due to intermittent hypoxia, which can cause increased sympathetic activation, insulin resistance, hyperlipidemia, and other negative effects. However, the causality assumptions are limited to cross-sectional data, and the presence of visceral obesity or other confounders challenges the ability to understand the independent contribution of OSA on MS. The article highlights the need for additional high-quality data from interventional studies to address the impact of established and promising therapies for OSA/obesity.
Like
Save
Share